Experimental Characterization of the Interaction between the N-Terminal SH3 Domain of Crkl and C3G.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Dec 2021
Historique:
received: 27 10 2021
revised: 25 11 2021
accepted: 03 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 3 2 2022
Statut: epublish

Résumé

Crkl is a protein involved in the onset of several cancer pathologies that exerts its function only through its protein-protein interaction domains, a SH2 domain and two SH3 domains. SH3 domains are small protein interaction modules that mediate the binding and recognition of proline-rich sequences. One of the main physiological interactors of Crkl is C3G (also known as RAPGEF1), an interaction with key implications in regulating cellular growth and differentiation, cell morphogenesis and adhesion processes. Thus, understanding the interaction between Crkl and C3G is fundamental to gaining information about the molecular determinants of the several cancer pathologies in which these proteins are involved. In this paper, through a combination of fast kinetics at different experimental conditions and site-directed mutagenesis, we characterize the binding reaction between the N-SH3 domain of Crkl and a peptide mimicking a specific portion of C3G. Our results show a clear effect of pH on the stability of the complex, due to the protonation of negatively charged residues in the binding pocket of N-SH3. Our results are discussed under the light of previous work on SH3 domains.

Identifiants

pubmed: 34947971
pii: ijms222413174
doi: 10.3390/ijms222413174
pmc: PMC8705818
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CRKL protein 0
Guanine Nucleotide-Releasing Factor 2 0
RAPGEF1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Sapienza University of Rome
ID : RP11715C34AEAC9B
Organisme : Sapienza University of Rome
ID : RM1181641C2C24B9
Organisme : Sapienza University of Rome
ID : RM11916B414C897E
Organisme : Italian Association for Cancer Research
ID : IG 24551
Organisme : Italian Pasteur Institute
ID : Ariaudo Research Project 2018
Organisme : Marie Skłodowska-Curie UBIMOTIF
ID : 860517

Références

J Biol Chem. 2011 Aug 5;286(31):27167-75
pubmed: 21653701
J Mol Biol. 1992 Apr 5;224(3):771-82
pubmed: 1569556
Blood. 1994 Nov 1;84(9):2912-8
pubmed: 7524758
FEBS Lett. 2002 Feb 20;513(1):38-44
pubmed: 11911878
J Mol Biol. 1999 Nov 19;294(1):271-88
pubmed: 10556045
Biochemistry. 1991 Oct 29;30(43):10428-35
pubmed: 1931967
FEBS Lett. 2012 Aug 14;586(17):2609-14
pubmed: 22710157
Science. 1993 Feb 19;259(5098):1157-61
pubmed: 8438166
Cells. 2021 Mar 27;10(4):
pubmed: 33801580
Nat Rev Mol Cell Biol. 2001 May;2(5):369-77
pubmed: 11331911
FEBS Lett. 2012 Aug 14;586(17):2606-8
pubmed: 22683951
J Biol Chem. 1999 May 14;274(20):14376-81
pubmed: 10318861
Sci Rep. 2019 Jun 4;9(1):8279
pubmed: 31164678
J Mol Biol. 2001 Mar 16;307(1):357-77
pubmed: 11243825
Chem Rev. 2009 Mar 11;109(3):839-60
pubmed: 19196002
J Biol Chem. 1994 Dec 30;269(52):32781-7
pubmed: 7806500
EMBO J. 2000 Dec 1;19(23):6382-91
pubmed: 11101511
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4679-84
pubmed: 18339805
Oncotarget. 2017 Jul 18;8(47):82344-82351
pubmed: 29137268
J Biol Chem. 1996 Jun 14;271(24):14468-72
pubmed: 8662907
Nature. 1994 Nov 24;372(6504):375-9
pubmed: 7802869
J Biol Chem. 2005 Oct 14;280(41):34805-12
pubmed: 16049001
Cell. 1994 Mar 11;76(5):933-45
pubmed: 7510218
Protein Sci. 1995 Oct;4(10):2138-48
pubmed: 8535251
EMBO J. 2001 Jun 15;20(12):2995-3007
pubmed: 11406576
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1540-4
pubmed: 8643668
Mol Cell Biol. 1995 Dec;15(12):6746-53
pubmed: 8524240
Biophys Chem. 2005 Aug 1;116(3):251-6
pubmed: 15896898
J Biol Chem. 2000 Apr 14;275(15):10772-8
pubmed: 10753869
J Biol Chem. 2009 Apr 24;284(17):10995-9
pubmed: 19091745
J Biol Chem. 1999 Dec 31;274(53):37525-32
pubmed: 10608804
EMBO J. 1995 May 15;14(10):2191-8
pubmed: 7774577
Structure. 1995 Feb 15;3(2):215-26
pubmed: 7735837

Auteurs

Livia Pagano (L)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.

Francesca Malagrinò (F)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.

Caterina Nardella (C)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.

Stefano Gianni (S)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.

Angelo Toto (A)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH